"
Team:UCSF/Project/Circuit/Data
From 2013.igem.org
(Difference between revisions)
| Line 33: | Line 33: | ||
</font></div> | </font></div> | ||
| - | <div id="description" style = "width:950px; height: | + | <div id="description" style = "width:950px; height:140px" align="justify"> |
<font face="calibri" size = "4"> | <font face="calibri" size = "4"> | ||
| - | + | Before we could create promoters that respond to a high and low amount of inducer, we first had to select promoters with two favorable characteristics we could exploit to make them concentration-dependent which would be a low basal level and a wide dynamic range. We chose four well-known promoters as possible candidates for our circuit: pLAC, pTet, pBAD, and PprpB. We constructed separate plasmids containing each of the promoters and characterized these promoters by measuring the GFP expression over time. We determined the basal level, highest induction level, and inducer range. We selected pLAC & pTET as the promoters for the synthetic circuit, because of their low basal expression and the varying responsiveness at different inducer concentrations. <br></div> | |
| - | + | ||
<div id="photos"> | <div id="photos"> | ||
| Line 61: | Line 60: | ||
<div id="description" style = "width:950px; height:100px" align="justify"> | <div id="description" style = "width:950px; height:100px" align="justify"> | ||
<font face="calibri" size = "4"> | <font face="calibri" size = "4"> | ||
| - | <FONT COLOR="#008000"><u> | + | <FONT COLOR="#008000"><u>Engineering pLAC Sensitivity </FONT COLOR="#008000"></u><br> |
<br>Our next goal after our promoter assays was to create engineered versions of our promoters responsive to high and low levels of inducer, either by modifying activation or repression of the specific promoter. Based on <a href="http://www.ncbi.nlm.nih.gov/pubmed/16432263">previous work</a> in the literature characterizing the pLAC promoter, we chose to change both the number and orientation of repressor binding sites in pLAC. | <br>Our next goal after our promoter assays was to create engineered versions of our promoters responsive to high and low levels of inducer, either by modifying activation or repression of the specific promoter. Based on <a href="http://www.ncbi.nlm.nih.gov/pubmed/16432263">previous work</a> in the literature characterizing the pLAC promoter, we chose to change both the number and orientation of repressor binding sites in pLAC. | ||
</div> | </div> | ||
| Line 75: | Line 74: | ||
<div id="photos"> | <div id="photos"> | ||
| - | <center><img style="height: | + | <center><img style="height:150px; margin-top:20px"; padding:0;" |
| - | src="https://static.igem.org/mediawiki/2013/ | + | src="https://static.igem.org/mediawiki/2013/4/41/PLAC_Prom_Eng_UCSF1.png"> |
| - | <div id="description" style = "width:700px; height: | + | <div id="description" style = "width:700px; height:70px; margin-left:120px" align="justify"> |
| - | <font face="calibri" size = "2"> | + | <font face="calibri" size = "2">On this diagram (A) denotes the very original pLAC which is found in the parts registry. (B) is our re-engineered pLAC that has an added O3 binding site. We found in literature that by adding an O3 binding site, a higher inducer level is required to start transcription for a loop to form between the 03 and 01 binding sites. We expect we would need more inducer to produce similar levels of GFP. |
</font> | </font> | ||
</div> | </div> | ||
Revision as of 17:36, 28 October 2013
Summary: We have designed a CRISPRi circuit that can choose between two outcomes based on the level of input This circuit is also scalable (i.e. many parallel circuits can be deployed in the same cell) due to the use of CRISPRi gRNA's
Before we could create promoters that respond to a high and low amount of inducer, we first had to select promoters with two favorable characteristics we could exploit to make them concentration-dependent which would be a low basal level and a wide dynamic range. We chose four well-known promoters as possible candidates for our circuit: pLAC, pTet, pBAD, and PprpB. We constructed separate plasmids containing each of the promoters and characterized these promoters by measuring the GFP expression over time. We determined the basal level, highest induction level, and inducer range. We selected pLAC & pTET as the promoters for the synthetic circuit, because of their low basal expression and the varying responsiveness at different inducer concentrations.
Dose-response curve for pLAC promoter induced with different amount of inducers (0, 0.1, 1, 10, 20, 40, 60, 80, 120 uM IPTG). Cells were grow to mid-log phase and then start induction. OD600 value and GFP fluorescence level of each sample were measured by plate reader after saturation. GFP fluorescence were corrected for OD600 value. The red line indicated Hill function fit of the dose-response curve and error bars indicate standard deviation calculated on the basis of technical replicates.
Dose-response curve for pTET promoter induced with different amount of inducers (0, 0.004, 0.01, 0.04, 0.06, 0.11 uM aTc). Cells were grow to mid-log phase and then start induction. OD600 value and GFP fluorescence level of each sample were measured by plate reader after saturation. GFP fluorescence were corrected for OD600 value. The red line indicated Hill function fit of the dose-response curve and error bars indicate standard deviation calculated on the basis of technical replicates.
Engineering pLAC Sensitivity
Our next goal after our promoter assays was to create engineered versions of our promoters responsive to high and low levels of inducer, either by modifying activation or repression of the specific promoter. Based on previous work in the literature characterizing the pLAC promoter, we chose to change both the number and orientation of repressor binding sites in pLAC.
Our next goal after our promoter assays was to create engineered versions of our promoters responsive to high and low levels of inducer, either by modifying activation or repression of the specific promoter. Based on previous work in the literature characterizing the pLAC promoter, we chose to change both the number and orientation of repressor binding sites in pLAC.
From Oehler et al., 2006.
To create our "low" inducer promoter, we shifted the O1 operator site further downstream of our promoter sequence and removed another operator site from pLAC to relieve repression. To create our "high" promoter, we took the "low" promoter and added the O3 operator site further upstream near the start of the promoter sequence. The O3 operator site will then form a loop with our O1 operator site, thus creating a physical barrier to prevent transcription, reducing the promoter activity at low levels of inducer.
On this diagram (A) denotes the very original pLAC which is found in the parts registry. (B) is our re-engineered pLAC that has an added O3 binding site. We found in literature that by adding an O3 binding site, a higher inducer level is required to start transcription for a loop to form between the 03 and 01 binding sites. We expect we would need more inducer to produce similar levels of GFP.
We are in the process of analyzing the data from our engineered promoters and are excited to present it at the Jamboree!
Using a similar GFP reporter system as for the first promoter tests, we were able to show (based on preliminary data) that our engineered pLAC promoters are now concentration sensors and can be used to create a circuit that responds differently to varying inducer levels. We plan to implement a similar strategy for the pTET promoter design to implement it in a parallel circuit.
Using a similar GFP reporter system as for the first promoter tests, we were able to show (based on preliminary data) that our engineered pLAC promoters are now concentration sensors and can be used to create a circuit that responds differently to varying inducer levels. We plan to implement a similar strategy for the pTET promoter design to implement it in a parallel circuit.
The essential benefit of using the CRISPR system for the circuit design is that it has a very specific target -- a guideRNA contains nucleotides which are complementary to a unique DNA sequence. As a result, we can use a vast number of individual gRNAs to repress several genes, giving us the ability to design circuits to make numerous and more complex decisions.
Our proof-of-concept design is, at a low level of inducer, to express GFP simultaneously with a gRNA to repress RFP. When the inducer level increases, the "high" sensing promoter turns on expression of RFP and a gRNA to repress GFP, making a switch-like decision based on the input. We were able to construct an early design of the circuit in the pCDF plasmid that contains both fluorescent proteins and gRNAs. We initially put both components of the circuit under individual promoters, pLAC and pTET, as a control to test whether or not we could obtain expression of both products and repression from the gRNAs, both under individual induction and after switching inducers. Since this circuit relies on CRISPR repression, we had to also construct a plasmid (pACYC) containing the catalytically dead dCas9 protein as well as the Csy4 protein to cleave the RNA products (see Design page or Parts Registry for more information).
We are in the final stages of cloning the dCas9 plasmid and we hope to test the circuit before the Jamboree.
